Page of

The current and future outlook for patients with axial spondyloarthritis 

The current and future outlook for patients with axial spondyloarthritis
Chapter:
The current and future outlook for patients with axial spondyloarthritis
Source:
Axial Spondyloarthritis (Oxford Rheumatology Library)
Author(s):

Stefan Siebert

, Sengupta Raj

, and Alexander Tsoukas

DOI:
10.1093/med/9780198755296.003.0016

There have been major advances in axial spondyloarthritis (axSpA) over the past decade. The current and future outlook for patients with axSpA is therefore much improved and largely positive. Despite this, there is still significant unmet need in pathophysiology, prevention, diagnosis, and treatment. While several new therapeutic agents are expected to reach the clinic over the next few years, the treatment of individual patients is likely to remain largely empiric. There is a need for the development of biomarkers and rationale stratified treatment approaches in order to capitalise on previous gains for the benefit of our patients.

Sign In

Copyright © 2021. All rights reserved.